Objective: The Canadian Ultra-Processed Product Screener (CUPS) was developed to rapidly assess ultra-processed food (UPF) and drink product intake among Canadian adults. The CUPS is an online self-administered screener that includes twenty-eight questions and assesses the intake of a variety of UPF available in Canada, both in French and English. This study aimed to assess the construct validity and reliability of the CUPS among a sample of adults in Canada. Design: Cross-sectional study (between July and November 2023). Settings: Participants completed the online CUPS screener in three versions (1-d (twice), 7-d and 30-d CUPS) and three 24-h dietary recalls (24HR) (the reference measure) over the course of 26–28 d. Participants: 354 Canadians aged 18–60 years Results: The CUPS had an acceptable construct validity, with moderate correlation coefficients between the CUPS score and UPF consumption level measured using multiple 24HR (from 0·33 to 0·44). Reproducibility was also acceptable (intraclass correlation = 0·61) and internal consistency ranged from good to excellent (Cronbach’s α = 0·72 for the 1-d and 0·86 for the 30-d CUPS). CUPS scores were also associated with higher intake of added sugars, saturated fats and Na. Conclusions: This study provides evidence supporting the construct validity and reliability of the CUPS among Canadian adults. The CUPS is useful for identifying low and high consumers of UPF and could serve as a proxy measure for one key dimension of diet quality, which is the type of food processing.
Objective: The 2025 Lancet Commission reframed obesity as an adiposity-based disease and introduced principles for defining and pursuing remission beyond body mass loss. This study applied a novel remission definition, assessed its prevalence after a real-world multidisciplinary lifestyle intervention, and examined sex differences.Methods: We retrospectively analyzed obesity remission in adults enrolled in a 12-month prediabetes and type 2 diabetes remission program. Obesity was defined as body mass index ≥25 kg/m² and waist circumference ≥88 cm (women) or ≥102 cm (men). Complete remission required absence of obesity criteria at both 6 and 12 months; partial remission at 12 months only. Intervention combined individualized Mediterranean-diet counseling with personalized aerobic and resistance training, without pharmacologic weight-loss therapy.Results: Among 142 participants, body mass index and waist circumference decreased by 1.8 kg/m² and 6.8 cm at 12 months. Men showed greater absolute reductions in body mass and visceral fat. Overall, 18% of participants achieved remission, with complete remission more frequent in men (OR=3.5, 95% CI 1.0 to 15.5; p=0.027). Conclusions: A structured multidisciplinary lifestyle program achieved meaningful reductions in adiposity and led to significant remission of obesity, with significant sex differences. Findings support the Commission’s framework and the importance of sex-specific, personalized approaches.